USD 0.65
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2022 | 62.46 Million USD | 143.94% |
2021 | 25.6 Million USD | -30.97% |
2020 | 37.09 Million USD | -3.79% |
2019 | 38.55 Million USD | -13.17% |
2018 | 44.4 Million USD | -7.06% |
2017 | 47.78 Million USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | -100.0% |
2012 | 8.57 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 Q2 | 70.19 Million USD | -8.04% |
2023 Q1 | 76.32 Million USD | 22.19% |
2022 Q4 | 62.46 Million USD | 1.75% |
2022 Q2 | 53.59 Million USD | 94.0% |
2022 Q3 | 61.39 Million USD | 14.55% |
2022 FY | 62.46 Million USD | 143.94% |
2022 Q1 | 27.62 Million USD | 7.88% |
2021 Q4 | 25.6 Million USD | -19.31% |
2021 Q1 | 36.06 Million USD | -2.77% |
2021 FY | 25.6 Million USD | -30.97% |
2021 Q3 | 31.73 Million USD | -6.4% |
2021 Q2 | 33.9 Million USD | -5.99% |
2020 Q3 | 38.97 Million USD | -3.45% |
2020 Q1 | 151.5 Million USD | 292.93% |
2020 Q2 | 40.37 Million USD | -73.35% |
2020 Q4 | 37.09 Million USD | -4.84% |
2020 FY | 37.09 Million USD | -3.79% |
2019 Q3 | 39.68 Million USD | -8.67% |
2019 FY | 38.55 Million USD | -13.17% |
2019 Q4 | 38.55 Million USD | -2.85% |
2019 Q2 | 43.45 Million USD | 3.46% |
2019 Q1 | 41.99 Million USD | -5.42% |
2018 Q2 | 46.71 Million USD | -2.41% |
2018 Q1 | 47.87 Million USD | 0.2% |
2018 FY | 44.4 Million USD | -7.06% |
2018 Q4 | 44.4 Million USD | 0.21% |
2018 Q3 | 44.31 Million USD | -5.15% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | 48.93 Million USD | 0.0% |
2017 Q4 | 47.78 Million USD | -2.36% |
2017 FY | 47.78 Million USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 FY | - USD | -100.0% |
2013 Q4 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | 8.57 Million USD | 0.0% |
2012 Q3 | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Theratechnologies Inc. | 58.96 Million USD | -5.932% |
Harrow Health, Inc. | 190.5 Million USD | 67.21% |
Dynavax Technologies Corporation | 256.91 Million USD | 75.686% |
Biofrontera Inc. | 5.39 Million USD | -1056.992% |
Cronos Group Inc. | 2.53 Million USD | -2359.351% |
Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -10174.013% |
Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 91.27% |
Kala Pharmaceuticals, Inc. | 36.32 Million USD | -71.974% |
RedHill Biopharma Ltd. | 1.17 Million USD | -5225.292% |
Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -238.964% |
Radius Health, Inc. | 365.31 Million USD | 82.901% |
Universe Pharmaceuticals INC | 5.48 Million USD | -1039.38% |
DURECT Corporation | 20.74 Million USD | -201.099% |
ProPhase Labs, Inc. | 21.38 Million USD | -192.17% |
Safety Shot Inc | 1.54 Million USD | -3932.734% |
Phibro Animal Health Corporation | 525.45 Million USD | 88.112% |
China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -2259.474% |
Alvotech | 1.07 Billion USD | 94.192% |
Assertio Holdings, Inc. | 40.91 Million USD | -52.684% |
Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -50.423% |
Rockwell Medical, Inc. | 13.43 Million USD | -364.811% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -9397.571% |
Procaps Group S.A. | 285.93 Million USD | 78.154% |
Intra-Cellular Therapies, Inc. | 16.93 Million USD | -268.792% |
SCYNEXIS, Inc. | 15.08 Million USD | -314.231% |
Aytu BioPharma, Inc. | 15.12 Million USD | -312.889% |
Viatris Inc. | 18.12 Billion USD | 99.655% |
OptiNose, Inc. | 131.74 Million USD | 52.587% |
SIGA Technologies, Inc. | 1.46 Million USD | -4166.777% |
Tilray Brands, Inc. | 387.31 Million USD | 83.872% |
PetIQ, Inc. | 468.3 Million USD | 86.661% |
Sunshine Biopharma, Inc. | 657.7 Thousand USD | -9397.571% |
Neurocrine Biosciences, Inc. | 428.4 Million USD | 85.419% |
Guardion Health Sciences, Inc. | - USD | -Infinity% |
Alimera Sciences, Inc. | 67.39 Million USD | 7.319% |
Collegium Pharmaceutical, Inc. | 674.28 Million USD | 90.736% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -5642.976% |
Organogenesis Holdings Inc. | 119.35 Million USD | 47.662% |
Journey Medical Corporation | 17.73 Million USD | -252.318% |
Petros Pharmaceuticals, Inc. | 8.27 Million USD | -654.731% |
Alpha Teknova, Inc. | 30.45 Million USD | -105.089% |
Clever Leaves Holdings Inc. | 2.08 Million USD | -2893.1% |
Lifecore Biomedical, Inc. | 130.36 Million USD | 52.082% |
PainReform Ltd. | 86 Thousand USD | -72534.884% |
Cosmos Health Inc. | 12.42 Million USD | -402.787% |
Avadel Pharmaceuticals plc | 35.38 Million USD | -76.537% |
TherapeuticsMD, Inc. | 8 Million USD | -680.337% |
Embecta Corp. | 1.63 Billion USD | 96.188% |
Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -104345.968% |
Talphera, Inc. | - USD | -Infinity% |
Pacira BioSciences, Inc. | 586.04 Million USD | 89.341% |
Incannex Healthcare Limited | 373 Thousand USD | -16646.917% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -5946.374% |
Shineco, Inc. | 29.65 Million USD | -110.632% |
Procaps Group, S.A. | 285.93 Million USD | 78.154% |
ANI Pharmaceuticals, Inc. | 315.32 Million USD | 80.19% |
Aquestive Therapeutics, Inc. | 98.82 Million USD | 36.789% |
Lantheus Holdings, Inc. | 616.94 Million USD | 89.875% |
Alvotech | 1.07 Billion USD | 94.192% |
Hempacco Co., Inc. | 13.72 Million USD | -355.142% |
Bright Green Corporation | 1.85 Million USD | -3273.289% |
Esperion Therapeutics, Inc. | 540.94 Million USD | 88.452% |
Kamada Ltd. | 8.74 Million USD | -613.98% |
Indivior PLC | 281.6 Million USD | 77.818% |
Evoke Pharma, Inc. | 5 Million USD | -1149.32% |
Flora Growth Corp. | 3.67 Million USD | -1601.144% |
Cyclo Therapeutics, Inc. | 1.03 Million USD | -5946.374% |
Evolus, Inc. | 126.54 Million USD | 50.638% |
HUTCHMED (China) Limited | 86.13 Million USD | 27.476% |
Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 89.984% |
Akanda Corp. | 3.99 Million USD | -1462.122% |